Keyphrases
Adult Patients
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Acute Lymphoblastic Leukemia
100%
Conditioning Regimen
100%
VP16
100%
Cyclophosphamide
85%
Total Body Irradiation
85%
Non-relapse Mortality
42%
Confidence Interval
28%
Hazard Ratio
28%
Overall Survival
28%
Stem Cell Transplantation
28%
Disease-free Survival
28%
Peripheral Blood
14%
Multivariate Analysis
14%
Overall Survival Rate
14%
5-year Survival
14%
Stem Cell Source
14%
Bone Marrow
14%
Relapse Rate
14%
Matched Donors
14%
Leukemia Patients
14%
Annualized Relapse Rate
14%
First Complete Remission
14%
Adult Acute Lymphoblastic Leukemia
14%
Second Complete Remission
14%
Medicine and Dentistry
Cyclophosphamide
100%
Allogeneic Stem Cell Transplantation
100%
Acute Lymphoblastic Leukemia
100%
Whole Body Radiation
100%
Conditioning
100%
Overall Survival
50%
Hazard Ratio
33%
Stem Cell Therapy
33%
Disease Free Survival
33%
Stem Cell
16%
Cumulative Incidence
16%
Survival Rate
16%
Multivariate Analysis
16%
Recurrence Risk
16%
Matched Donor
16%
Immunology and Microbiology
Allogeneic Stem Cell Transplantation
100%
Cyclophosphamide
100%
Conditioning
100%
Overall Survival
50%
Stem Cell Transplantation
33%
Disease Free Survival
33%
Stem Cell
16%
Survival Rate
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
100%
Acute Lymphoblastic Leukemia
100%
Overall Survival
50%
Disease Free Survival
33%
Survival Rate
16%
Remission
16%
Recurrence Risk
16%
Nursing and Health Professions
Acute Lymphoblastic Leukemia
100%
Allogeneic Stem Cell Transplantation
100%
Stem Cell Therapy
33%
Matched Donor
16%